NDRA: SEC Form 425 filed by ENDRA Life Sciences Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for NDRA
Across the 10 sessions after earlier NDRA headlines, the stock closed higher 5 times and lower 4 times, with a median move of 6.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | NDRA | SPY |
|---|---|---|---|
| May 18, 2026 | ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update | +7.1% | -0.1% |
| May 14, 2026 | ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility | +1.4% | +0.8% |
| Apr 1, 2026 | ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | +0.0% | +0.8% |
| Mar 25, 2026 | ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value | +8.4% | +0.6% |
| Feb 26, 2026 | ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care | +2.9% | -0.6% |
| Dec 4, 2025 | ENDRA's TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use | -7.7% | +0.1% |
Quantisnow market dataNASDAQ
NDRA
ENDRA Life Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Get push alerts for NDRA
Full NDRA profile on Quantisnow Follow NDRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time